Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.85 EUR | -2.85% | -4.44% | +15.40% |
May. 09 | Mutares Sells Portfolio Company iinovis Group to Accursia Capital | MT |
May. 07 | Mutares SE & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.15 for the 2024 fiscal year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 6 times its estimated earnings per share for the ongoing year.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.40% | 926M | C | ||
-5.26% | 94.17B | C- | ||
+19.64% | 27.7B | B- | ||
-1.00% | 18.41B | - | B+ | |
+4.45% | 15.29B | C+ | ||
+15.26% | 15.55B | B | ||
-20.31% | 12.49B | C+ | ||
+24.50% | 9.29B | C- | ||
+13.56% | 9.3B | B | ||
+26.56% | 7.11B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MUX Stock
- Ratings Mutares SE & Co. KGaA